The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBCN.L Share News (BCN)

  • There is currently no data for BCN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SMALL-CAP WINNERS & LOSERS: Dr Martens Puts Best Foot Forward

Wed, 03rd Feb 2021 10:50

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Wednesday.

----------

SMALL-CAP - WINNERS

----------

Dr Martens, 452.16p, up 22% from initial public offering price of 370p. The iconic boot maker said its entire share capital has begun trading on London's Main Market on Wednesday, with a market value of around GBP4.5 billion putting Dr Martens easily in contention for a spot in the FTSE 250 index of mid-caps.

----------

Volution Group, up 5.5% at 308.57 pence, 12-month range 122.46p-313p. The ventilation products supplier said it is "pleased" with its strong trading performance and also has agreed to buy Swedish ventilation equipment maker Nordiska Klimatfabriken.

----------

STV Group up 5.0% at 347.56p, 12-month range, 210p-452.83p. The Glasgow-based television broadcaster said it saw a record-breaking performance in January for its free streaming service STV Player, with the release of exclusive drama box sets driving viewer growth. STV said total steams for STV Player are up over 100% to 12.5 million streams when compared to a year prior. The number of monthly active users on the service grew by 20% in January.

----------

Standard Life Investments Property, up 4.9% at 60.80p, 12-month range 43.51p-993p. The property investor said net asset value per share as at December 31 was up 4.1% to 82.0p from 78.8p.

----------

4D Pharma, up 4.6% at 120.83p, 12-month range 23.5p-183p. The pharmaceutical company said enrolment is progressing well both for part B of the MRx0518 and Keytruda combination study and for its pancreatic cancer study. 4D said 24 additional patients across five active US sites have been treated in part B of the study, consisting of 12 patients with renal cell carcinoma, 9 patients with non-small cell lung cancer, and 3 bladder cancer patients.

----------

SMALL-CAP - LOSERS

----------

Bacanora Lithium, down 15% at 47.40p, 12-month range 14.5p-69p. The lithium explorer said it successfully raised approximately USD65 million through the placing of shares as well as a retail offer. A total of 101.4 million shares were placed at 45 pence each, raising proceeds of about USD62 million, while an extra USD3 million was raised after retail and other investors subscribed for 5.6 million shares.

----------

Porvair, down 2.5% at 525.75p, 12-month range 370p-796.47p. The filtration, laboratory and environmental technology firm's shares were continuing to fall after it said earlier this week that near-term trading remains unpredictable and continued to withhold earnings guidance. The stock is down 8.4% since last Thursday.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
5 Feb 2021 11:06

IN BRIEF: Bacanora Says Gangfeng To Make USD31 Million Investment

IN BRIEF: Bacanora Says Gangfeng To Make USD31 Million Investment

Read more
4 Feb 2021 12:55

Thursday broker round-up

(Sharecast News) - GSK: Deutsche Bank downgrades to sell with a target price of 1,150p.

Read more
3 Feb 2021 10:23

Bacanora Step Closer To Becoming Lithium Producer Following Placing

Bacanora Step Closer To Becoming Lithium Producer Following Placing

Read more
2 Feb 2021 19:06

IN BRIEF: Bacanora Lithium To Raise USD60 Million For Sonora Costs

IN BRIEF: Bacanora Lithium To Raise USD60 Million For Sonora Costs

Read more
1 Feb 2021 19:13

IN BRIEF: Bacanora Partner Signs New JV After Upped Stake In Sonora

IN BRIEF: Bacanora Partner Signs New JV After Upped Stake In Sonora

Read more
13 Nov 2020 16:54

IN BRIEF: Bacanora Says Ganfeng Exercises Sonora Option

IN BRIEF: Bacanora Says Ganfeng Exercises Sonora Option

Read more
13 Nov 2020 15:03

Ganfeng ups stake in Bacanora's Sonora Lithium

(Sharecast News) - Bacanora Lithium announced on Friday that the board of its cornerstone investor and offtake partner Ganfeng Lithium has approved the exercise of its option to increase its stake in Sonora Lithium (SLL) to 50%, from 22.5%.

Read more
8 Oct 2020 19:30

Erris Surges As It Acquires Bacanora's 50% Stake In Lithium Asset

Erris Surges As It Acquires Bacanora's 50% Stake In Lithium Asset

Read more
30 Sep 2020 14:04

Bacanora In Talks To Sell Stake In German Lithium Project To Erris

Bacanora In Talks To Sell Stake In German Lithium Project To Erris

Read more
10 Sep 2020 16:07

Bacanora remains on track at Sonora Lithium Project

(Sharecast News) - Exploration and development company Bacanora Lithium updated the market on activities at its Sonora Lithium Project in Mexico on Thursday, reporting that the pilot plant had completed the bulk sampling required for the plant and engineering designs.

Read more
10 Sep 2020 16:01

UK TRADING UPDATE SUMMARY: Prime People Hurt As Covid Hits Job Market

UK TRADING UPDATE SUMMARY: Prime People Hurt As Covid Hits Job Market

Read more
4 Jun 2020 16:35

REPEAT: UK Shareholder Meetings Calendar - Next 7 Days

REPEAT: UK Shareholder Meetings Calendar - Next 7 Days

Read more
29 May 2020 13:18

Friday broker round-up

(Sharecast News) - Admiral Group: Barclays downgrades to equal weight with a target price of 2,304p.

Read more
28 May 2020 14:49

UK TRADING UPDATE SUMMARY: PureTech, N4, Synairgen Advance Covid Work

UK TRADING UPDATE SUMMARY: PureTech, N4, Synairgen Advance Covid Work

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.